The 3 key substances that make up the product are:

•   Cannabis sativa (Hemp Oil)
•   EPA70% Concentrate (Omega 3)
•   harpago

WeConfort ^® promotes the vitality and general well-being of dogs and cats, in different situations:

• Geriatric animals, where there is a deficit in sensory functions;
• Animals that show processes that lead to chronic pain states;
• Animals exposed to conditions of high oxidative stress;
• Animals that show chronic states of tiredness or fatigue;
• All situations of chronic pain associated with osteoarthritis, especially those only controlled with the use of NSAIDs.

Chronic Pain Conditions
The most common causes of chronic pain include, among others, the main conditions:

• Osteoarthritis (OA).
• Neoplasm and cancer-associated therapy (eg, chemotherapy-induced neuropathy, radiation-induced skin burns).
• Persistent Post-Surgical Pain (eg, limb or tail amputation, thoracotomy, onicectomy).
• Oral and periodontal disease (eg, gingivitis, periodontitis, stomatitis, FOPS).
• Gastrointestinal disease (eg, inflammatory bowel disease, megacolon, constipation, pancreatitis, cholangiohepatitis).
• Ophthalmic disease (eg, corneal disease, uveitis, ulcers).
• Urogenital disease (eg interstitial cystitis, chronic kidney disease).
• Dermatological disease (eg otitis, severe pruritus, burns, chronic wounds).
• Diabetes-induced neuropathy.
• Hyperesthesia syndrome.

Cannabis Sativa – Hemp Oil

Hemp Oil has cannabidiol (CBD) with modulating activity on the Endocannabinoid System (SEC). In situations of pain associated with inflammation or hyperalgesia, exogenous cannabinoids, such as CBD, produce different levels of analgesia. In addition to all the functions associated with the Endocannabinoid System, hemp oil has a high concentration of essential fatty acids, functioning as a potent antioxidant.

Harpagophytum procumbens

WeConfort ^® contains a Concentrated Dry Extract of Harpago, resulting from the elimination of "impurities" and concentration of the active nutraceutical molecule. It has anti-inflammatory and analgesic properties, particularly in the treatment of painful joint manifestations. Studies indicate that it can inhibit both pathways of arachidonic acid metabolism, the cyclooxygenase (COX) pathway and the lipoxygenase (LOX) pathway, reducing the production of eicosanoids such as prostaglandins. Regarding the inhibition of the COX pathway, harpago seems to specifically inhibit COX-2, but not COX-1, which may explain its high tolerance and reduced side effects, unlike the old NSAIDs that inhibit the isoforms. enzyme non-specific.

Omega 3 (70% EPA Concentrated)

Currently, and through technological processes, it is possible to separate the different substances that constitute the Omega 3, namely eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). Recent studies associate DHA with the support of degenerative processes, while EPA with different metabolic processes in which the inflammatory component is critical.

Supplementation with EPA demonstrates positive effects on lipid metabolism, suppression of body fat accumulation, reduction of insulin resistance and hepatic steatosis. Administration of EPA promotes the synthesis of anti-inflammatory eicosanoids, such as prostaglandin PG-3 and Leukotriene LT-5, and reduce the synthesis of other highly inflammatory eicosanoids.

Actives per WeConfort ^® Capsule:

Fish Oil (Omega 3 concentrated in EPA) - 588.5 mg; Eicosapentaenoic acid (EPA) - 400.00 mg; Docosahexaenoic acid (DHA) - 47.08 mg; Cannabis sativa (Seed Oil)* - 25 mg; Concentrated Dry Extract - 12 mg; Harpagophytum procumbens, Harpago (Root)

*Seed oil obtained by cold pressing. THC content <0.2%

Composition per/kg

*equivalent to: 407.62g of eicosapentaenoic acid (EPA)//47.98g of docosahexaenoic acid (DHA)

**seed oil obtained by cold pressing. THC content <0.2%

Additives (per kg): Organoleptic Additives:

Flavoring compounds: Botanically defined natural products: Harpagophytum procumbens extract, Harpago (root) - 12.23g

Colorants: Titanium Dioxide(E171)0.86g; Allura Red(E129)0.30g

Technological additives: Emulsifiers: Lectin(1c322i) - 3.06g

Analytical Constituents (theoretical analysis): Crude Protein 17.9%; Gross Fat: 62.8%; Crude Fiber: 1.1%; Raw Ash: 2.2%; Moisture content: 1.9%

Animals up to 8 kg: 1 capsule every other day.
Animals from 8 to 16 kg: 1 capsule/day.
Animals from 16 to 40 kg: 2 capsules/day.
Animals over 40 kg: 3 capsules/day.

WeConfort® can be administered directly into the mouth or the contents of the capsule placed on the animal's food.

Store in a dry place in the original packaging and at a temperature below 25°C.

Preserve from light and heat. Keep out of the reach and sight of children .